The FINANCIAL -- Health care professionals tend to underestimate a patient’s willingness to discuss their weight and treatment options.

The FINANCIAL -- Bayer, together with its cooperation partner, Janssen Research & Development, L.L.C., announced today that the US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application filed on December 29, 2011 for the oral anticoagulant Xarelto in combination with standard antiplatelet therapy to reduce the risk of cardiovascular events in patients with Acute Coronary Syndrome.

The FINANCIAL -- The number of patients visiting hospitals for preventive examinations has increased in Georgia. Doctors are saying that this is a result of the development of the insurance market and healthcare programmes provided by the Ministry of Health.

The FINANCIAL -- Arena Pharmaceuticals,announced that the company is scheduled to present at the Citi 2012 Global Health Care Conference on Wednesday, February 29, 2012, at 1:30 p.m. Eastern Time at the Waldorf=Astoria in New York City. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide a corporate overview.